CONTRACEPTIVE PATCH BIBLIOGRAPHY

1. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). J Fam Plann Reprod Health Care. Jan 2004;30(1):43-45.
Link to PubMed

2. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril. Feb 2002;77(2 Suppl 2):S3-12.
Link to PubMed

3. Abrams LS, Skee DM, Natarajan J, Wong FA, Lasseter KC. Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants. Contraception. Nov 2001;64(5):287-294.
Link to PubMed

4. Abrams LS, Skee DM, Natarajan J, et al. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise. J Clin Pharmacol. Dec 2001;41(12):1301-1309.
Link to PubMed

5. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril. Feb 2002;77(2 Suppl 2):S27-31.
Link to PubMed

6. Archer DF, Cullins V, Creasy GW, Fisher AC. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception. Mar 2004;69(3):189-195.
Link to PubMed

7. Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. Jama. May 9 2001;285(18):2347-2354.
Link to PubMed

8. Banerjee S. Transdermal contraceptive patch--a new birth control option. Issues Emerg Health Technol. Nov 2001(26):1-4.
Link to PubMed

9. Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. Aug 2003;70(8):681-682, 685-686, 668-690 passim.
Link to PubMed

10. Burkman RT. The transdermal contraceptive patch: a new approach to hormonal contraception. Int J Fertil Womens Med. Mar-Apr 2002;47(2):69-76.
Link to PubMed

11. Burkman RT. The transdermal contraceptive system. Am J Obstet Gynecol. Apr 2004;190(4 Suppl):S49-53.
Link to PubMed

12. Calderoni ME, Coupey SM. Combined hormonal contraception. Adolesc Med Clin. Oct 2005;16(3):517-537.
Link to PubMed

13. Creasy GW, Abrams LS, Fisher AC. Transdermal contraception. Semin Reprod Med. Dec 2001;19(4):373-380.
Link to PubMed

14. Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC. Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. Am J Obstet Gynecol. Jan 2002;186(1):15-20.
Link to PubMed

15. Forinash AB, Evans SL. New hormonal contraceptives: a comprehensive review of the literature. Pharmacotherapy. Dec 2003;23(12):1573-1591.
Link to PubMed

16. Freeman S. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling. J Am Acad Nurse Pract. Jun 2004;16(6):226-238.
Link to PubMed

17. Gallo MF, Grimes DA, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2003(1):CD003552.
Link to PubMed

18. Gallo MF, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2003(2):CD003987.
Link to PubMed

19. Gallo MF, Grimes DA, Schulz KF, Helmerhorst FM. Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol. Feb 2004;103(2):359-373.
Link to PubMed

20. Goa KL, Warner GT, Easthope SE. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Treat Endocrinol. 2003;2(3):191-206.
Link to PubMed

21. Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol. Apr 2005;18(2):85-90.
Link to PubMed

22. Heger-Mahn D, Warlimont C, Faustmann T, Gerlinger C, Klipping C. Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers. Eur J Contracept Reprod Health Care. Sep 2004;9(3):173-181.
Link to PubMed

23. Herndon EJ, Zieman M. New contraceptive options. Am Fam Physician. Feb 15 2004;69(4):853-860.
Link to PubMed

24. Johansson ED. Future developments in hormonal contraception. Am J Obstet Gynecol. Apr 2004;190(4 Suppl):S69-71.
Link to PubMed

25. Kaunitz AM. Beyond the pill: new data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol. Apr 2005;192(4):998-1004.
Link to PubMed

26. Linn ES. Progress in contraception: new technology. Int J Fertil Womens Med. Jul-Aug 2003;48(4):182-191.
Link to PubMed

27. Rubinstein ML, Halpern-Felsher BL, Irwin CE, Jr. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health. May 2004;34(5):395-401.
Link to PubMed

28. Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril. Feb 2002;77(2 Suppl 2):S19-26.
Link to PubMed

29. Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol. Nov 2001;98(5 Pt 1):799-805.
Link to PubMed

30. Sonnenberg FA, Burkman RT, Speroff L, Westhoff C, Hagerty CG. Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch. Am J Obstet Gynecol. Jan 2005;192(1):1-9.
Link to PubMed

31. Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol. Jun 2005;105(6):1389-1396.
Link to PubMed

32. Urdl W, Apter D, Alperstein A, et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol. Aug 1 2005;121(2):202-210.
Link to PubMed

33. van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. Sep 2005;72(3):168-174.
Link to PubMed

34. Weisberg F, Bouchard C, Moreau M, et al. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. J Obstet Gynaecol Can. Apr 2005;27(4):350-359.
Link to PubMed

35. Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril. Feb 2002;77(2 Suppl 2):S32-35.
Link to PubMed

36. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. Feb 2002;77(2 Suppl 2):S13-18.
Link to PubMed